Corresponding author: Peter Bede, Computational Neuroimaging Group, Trinity Biomedical Sciences Institute, Trinity College Dublin; email: bedep@tcd.ie Abstract One of the central aspects of clinical heterogeneity in motor neuron diseases is the respective involvement of upper (UMN) and lower motor neurons (LMN). Pure UMN and LMN phenotypes are associated with longer survival than mixed UMN-LMN conditions. The majority of longitudinal imaging studies in MND focus on a specific condition and describe progressive changes in contrast to healthy populations. The juxtaposition of cortical trajectories in several MNDs allows the characterisation of differences in rate of progression, and highlights anatomical patterns of disease burden unique to...
Amyotrophic lateral sclerosis (ALS) has heterogeneous clinical features that could be translated int...
BACKGROUND AND PURPOSE: To date, damage of the cerebral cortex neurons in ALS was investigated by us...
A key area-of-need in motor neuron disease/amyotrophic lateral sclerosis (MND/ALS) translational res...
Item does not contain fulltextOBJECTIVES: Amyotrophic lateral sclerosis (ALS) is a fatal disease cha...
Objective: To understand the progressive nature of amyotrophic lateral sclerosis (ALS) by investigat...
Objective: Examine whether cortical thinning is a disease-specific phenomenon across the spectrum of...
Brainstem pathology is a pathognomonic feature of ALS encompassing lower cranial nerve and descendin...
Background: The criteria for assessing upper motor neuron pathology in pure lower motor neuron disea...
BACKGROUND AND PURPOSE: Primary lateral sclerosis (PLS) is a rare form of motor neuron disease chara...
Objective: To examine whether the distribution of prefrontal cortical thickness in patients with mot...
Amyotrophic lateral sclerosis (ALS) is a progressive disease of the motor system involving both uppe...
Neuropathological studies revealed the propagation of amyotrophic lateral sclerosis (ALS) in a seque...
Advances in neuroimaging, complementing histopathological insights, have established a multi-system ...
We aimed to quantitatively characterize progressive brain network disruption in Amyotrophic Lateral ...
Objective. To investigate structural and functional neural organization in amyotrophic lateral scler...
Amyotrophic lateral sclerosis (ALS) has heterogeneous clinical features that could be translated int...
BACKGROUND AND PURPOSE: To date, damage of the cerebral cortex neurons in ALS was investigated by us...
A key area-of-need in motor neuron disease/amyotrophic lateral sclerosis (MND/ALS) translational res...
Item does not contain fulltextOBJECTIVES: Amyotrophic lateral sclerosis (ALS) is a fatal disease cha...
Objective: To understand the progressive nature of amyotrophic lateral sclerosis (ALS) by investigat...
Objective: Examine whether cortical thinning is a disease-specific phenomenon across the spectrum of...
Brainstem pathology is a pathognomonic feature of ALS encompassing lower cranial nerve and descendin...
Background: The criteria for assessing upper motor neuron pathology in pure lower motor neuron disea...
BACKGROUND AND PURPOSE: Primary lateral sclerosis (PLS) is a rare form of motor neuron disease chara...
Objective: To examine whether the distribution of prefrontal cortical thickness in patients with mot...
Amyotrophic lateral sclerosis (ALS) is a progressive disease of the motor system involving both uppe...
Neuropathological studies revealed the propagation of amyotrophic lateral sclerosis (ALS) in a seque...
Advances in neuroimaging, complementing histopathological insights, have established a multi-system ...
We aimed to quantitatively characterize progressive brain network disruption in Amyotrophic Lateral ...
Objective. To investigate structural and functional neural organization in amyotrophic lateral scler...
Amyotrophic lateral sclerosis (ALS) has heterogeneous clinical features that could be translated int...
BACKGROUND AND PURPOSE: To date, damage of the cerebral cortex neurons in ALS was investigated by us...
A key area-of-need in motor neuron disease/amyotrophic lateral sclerosis (MND/ALS) translational res...